George M. Gould
Algemeen Adviseur bij Gibbons Del Deo Dolan Griffinger & Vecchione
Profiel
George M.
Gould is currently working as Counsel at Gibbons Del Deo Dolan Griffinger & Vecchione and Counsel at Gibbons PC.
He is also the Principal at Mr. Gould LLC.
In the past, he worked as Vice President at Hoffmann-La Roche, Inc. and as Director at Protein Design Labs, Inc., Tapestry Pharmaceuticals, Inc., BioSpecifics Technologies Corp., Angiogenex, Inc., and Supratek Pharma, Inc. He was also Senior Vice President at PharmaGenics, Inc. Mr. Gould completed his undergraduate degree from The Johns Hopkins University and his graduate degrees from Columbia Law School and New York University School of Law.
Actieve functies van George M. Gould
| Bedrijven | Functie | Begin |
|---|---|---|
Gibbons Del Deo Dolan Griffinger & Vecchione
 Gibbons Del Deo Dolan Griffinger & Vecchione Miscellaneous Commercial ServicesCommercial Services Gibbons Del Deo Dolan Griffinger & Vecchione provides legal services. The company is headquartered in Newark, NJ. | Algemeen Adviseur | 01-01-1996 |
Gibbons PC
 Gibbons PC Miscellaneous Commercial ServicesCommercial Services Gibbons P.C. provides legal services. It offers business and commercial litigation, corporate, government affairs, criminal defense and employment law. The company was founded in 1926 and is headquartered in Newark, NJ. | Corporate Officer/Principal | 01-01-1996 |
| George M. Gould LLC | Corporate Officer/Principal | - |
Eerdere bekende functies van George M. Gould
| Bedrijven | Functie | Einde |
|---|---|---|
| BIOSPECIFICS TECHNOLOGIES CORP. | Directeur/Bestuurslid | 08-11-2017 |
Protein Design Labs, Inc.
 Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Protein Design Labs, Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a company of development of humanized antibodies, It has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products. | Directeur/Bestuurslid | 10-01-2006 |
| Angiogenex, Inc. /Old/ | Directeur/Bestuurslid | 03-01-2006 |
PharmaGenics, Inc.
 PharmaGenics, Inc. Miscellaneous Commercial ServicesCommercial Services PharmaGenics, Inc. develops therapeutic products for cancer. The American company was founded by Mike I. Sherman. PharmaGenics was acquired by Genzyme Corp., part of Sanofi from April 08, 2011 on June 18, 1997 for $112 million. | Corporate Officer/Principal | 01-12-1996 |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | 01-01-1996 |
Opleiding van George M. Gould
| The Johns Hopkins University | Undergraduate Degree |
| Columbia Law School | Graduate Degree |
| New York University School of Law | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 10 |
|---|---|
Protein Design Labs, Inc.
Protein Design Labs, Inc. Pharmaceuticals: MajorHealth Technology Protein Design Labs, Inc. is a biopharmaceutical company focused on the research, development and commercialization of novel therapies for inflammation and autoimmune diseases, acute cardiac conditions and cancer. PDL markets several biopharmaceutical products in the United States through its hospital sales force and wholly-owned subsidiary, ESP Pharma, Inc. As a company of development of humanized antibodies, It has licensed its patents to numerous pharmaceutical and biotechnology companies, some of which are now paying royalties on net sales of licensed products. | Health Technology |
Tapestry Pharmaceuticals, Inc.
 Tapestry Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Tapestry Pharmaceuticals, Inc. develops, manufactures, and markets an anti-cancer pharmaceutical called Paclitaxel. It focuses on the development of proprietary therapies for the treatment of cancer, new products and technologies may involve the examination of individual molecules and classes of compounds. The company was founded in 1991 and is headquartered in Ankeny, IA. | Health Technology |
Gibbons Del Deo Dolan Griffinger & Vecchione
Gibbons Del Deo Dolan Griffinger & Vecchione Miscellaneous Commercial ServicesCommercial Services Gibbons Del Deo Dolan Griffinger & Vecchione provides legal services. The company is headquartered in Newark, NJ. | Commercial Services |
| Angiogenex, Inc. /Old/ | Health Technology |
PharmaGenics, Inc.
PharmaGenics, Inc. Miscellaneous Commercial ServicesCommercial Services PharmaGenics, Inc. develops therapeutic products for cancer. The American company was founded by Mike I. Sherman. PharmaGenics was acquired by Genzyme Corp., part of Sanofi from April 08, 2011 on June 18, 1997 for $112 million. | Commercial Services |
Gibbons PC
Gibbons PC Miscellaneous Commercial ServicesCommercial Services Gibbons P.C. provides legal services. It offers business and commercial litigation, corporate, government affairs, criminal defense and employment law. The company was founded in 1926 and is headquartered in Newark, NJ. | Commercial Services |
Supratek Pharma, Inc.
 Supratek Pharma, Inc. Pharmaceuticals: MajorHealth Technology Supratek Pharma, Inc. develops drugs and related oncology therapeutic products. It offers injectable chemotherapeutic that enhances or enables an approved anticancer drug. The firm’s products include SP1014C - a novel cabazitaxel against drug resistant prostate cancer, SP1030C - novel bendamustine against chronic lymphocytic leukemia and non-Hodgkin’s lymphoma and SP1049C - a novel injectable anthracycline platform drug against chemoresistant cancers. The company was founded by Valery Alakhov in 1994 and is headquartered in Pointe-Claire, Canada. | Health Technology |
BioSpecifics Technologies Corp.
 BioSpecifics Technologies Corp. Pharmaceuticals: MajorHealth Technology BioSpecifics Technologies Corp. engages in the development of an injectable collagenase clostridium histolyticum for multiple indications. It sells its products under the brand XIAFLEX. The company was founded in 1990 and is headquartered in Lynbrook, NY. | Health Technology |
| George M. Gould LLC | |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
